Correlation Between Kymera Therapeutics and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Foghorn Therapeutics, you can compare the effects of market volatilities on Kymera Therapeutics and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Foghorn Therapeutics.
Diversification Opportunities for Kymera Therapeutics and Foghorn Therapeutics
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Kymera and Foghorn is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Kymera Therapeutics and Foghorn Therapeutics
Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 1.18 times more return on investment than Foghorn Therapeutics. However, Kymera Therapeutics is 1.18 times more volatile than Foghorn Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 4,089 in Kymera Therapeutics on November 2, 2024 and sell it today you would lose (44.00) from holding Kymera Therapeutics or give up 1.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kymera Therapeutics vs. Foghorn Therapeutics
Performance |
| Timeline |
| Kymera Therapeutics |
| Foghorn Therapeutics |
Kymera Therapeutics and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kymera Therapeutics and Foghorn Therapeutics
The main advantage of trading using opposite Kymera Therapeutics and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |